Cargando…

Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis

OBJECTIVES: To determine whether development of ANCA-associated vasculitis (AAV) shows a relationship with a prior infection and if prior infection affects disease characteristics and outcome. METHODS: All incident cases of AAV diagnosed in a defined region of Sweden from 2000 through 2016 were iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rathmann, Jens, Stamatis, Pavlos, Jönsson, Göran, Englund, Martin, Segelmark, Mårten, Jayne, David, Mohammad, Aladdin J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707308/ https://www.ncbi.nlm.nih.gov/pubmed/35289842 http://dx.doi.org/10.1093/rheumatology/keac163

Ejemplares similares

Stable incidence but increase in prevalence of ANCA-associated vasculitis in southern Sweden: a 23-year study
por: Rathmann, Jens, et al.
Publicado: (2023)

Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis
por: Ekman, Diana, et al.
Publicado: (2023)

Neutrophil Extracellular Traps in ANCA-Associated Vasculitis
por: Söderberg, Daniel, et al.
Publicado: (2016)

Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA
por: Dahlqvist, Johanna, et al.
Publicado: (2021)

High risk of stroke in ANCA-associated vasculitis—a population-based study
por: Tabakovic, Dennis, et al.
Publicado: (2022)

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination
por: Eindhoven, Stefanie, et al.
Publicado: (2017)

POS-851 MPO-ANCA ASSOCIATED VASCULITIS AFTER COVID-19
por: GARCIA-VEGA, A., et al.
Publicado: (2022)

Proteomic profile of uninvolved versus crescentic glomeruli in MPO-ANCA-associated vasculitis
por: Sethi, Amit, et al.
Publicado: (2023)

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab
por: Bruchfeld, Annette, et al.
Publicado: (2021)

Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study
por: Ozaki, Shoichi, et al.
Publicado: (2011)

Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection
por: Voorzaat, Bram M., et al.
Publicado: (2017)

Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?
por: O'Sullivan, Kim M., et al.
Publicado: (2021)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2021)

Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis
por: Abdgawad, Mohamed, et al.
Publicado: (2012)

A Case of Concurrent MPO-/PR3-Negative ANCA-Associated Glomerulonephritis and Membranous Glomerulopathy
por: Nakada, Yasuyuki, et al.
Publicado: (2015)

The role of myeloperoxidase and myeloperoxidase–antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis
por: Arimura, Yoshihiro, et al.
Publicado: (2013)

Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis
por: Ohlsson, Sophie, et al.
Publicado: (2009)

PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease
por: Chen, Dhruti P., et al.
Publicado: (2023)

Double-Positive Anti-GBM and ANCA-MPO Vasculitis Presenting With Crescentic Glomerulonephritis
por: Pacheco, Mariana, et al.
Publicado: (2021)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study
por: van Eeden, Charmaine, et al.
Publicado: (2023)

MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
por: Obata, Shota, et al.
Publicado: (2021)

Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies
por: O’Brien, Eóin C., et al.
Publicado: (2015)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

Membranous Nephropathy With MPO-ANCA-Associated Crescentic GN
por: Kanodia, Kamal, et al.
Publicado: (2014)

MPO-C-ANCA-associated necrotising and crescentic glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2017)

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series
por: Caroti, L., et al.
Publicado: (2019)

MPO-ANCA-associated vasculitis in the context of autoimmune polyglandular syndrome type 3: case report and literature review
por: Dikovec, Cédric, et al.
Publicado: (2022)

ANCA-Positive Patients: The Influence of PR3 and MPO Antibodies on Survival Rate and The Association with Clinical and Laboratory Characteristics
por: Drooger, J.C, et al.
Publicado: (2009)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Clinical implications of serum thrombomodulin in PR3-ANCA-associated vasculitis
por: Zycinska, K, et al.
Publicado: (2009)

Altered circulating CCR6(+)and CXCR3(+) T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis
por: Liao, Zhonghua, et al.
Publicado: (2021)

A Case Report Describing a Rare Presentation of Simultaneous Occurrence of MPO-ANCA-Associated Vasculitis and Rheumatoid Arthritis
por: Foray, Nathalie, et al.
Publicado: (2016)

Reactivity against Complementary Proteinase-3 Is Not Increased in Patients with PR3-ANCA-Associated Vasculitis
por: Tadema, Henko, et al.
Publicado: (2011)

Dual-Positive MPO- and PR3-ANCA-Associated Vasculitis Following SARS-CoV-2 mRNA Booster Vaccination: A Case Report and Systematic Review
por: Baier, Eva, et al.
Publicado: (2022)

Pyoderma gangrenosum–like facial ulcers in a woman associated with cocaine use and cANCA/anti-PR3(+), pANCA/anti-MPO(–) serology
por: McBride, Jeffrey D., et al.
Publicado: (2020)

An Autopsy Case of Myeloperoxidase-anti-neutrophil Cytoplasmic Antibody (MPO-ANCA)-associated Vasculitis Accompanied by Cryoglobulinemic Vasculitis Affecting the Kidneys, Skin, and Gastrointestinal Tract
por: Hasegawa, Jumpei, et al.
Publicado: (2018)

ANCA Associated Vasculitis Subtypes: Response [Letter]
por: Merkel, Peter A, et al.
Publicado: (2022)

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab()
por: Baldallo, Cinthia, et al.
Publicado: (2021)

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
por: Kim, Beop Chang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_51451ma48t6i2tar89q5fcjq0i